Global Blood Proteomics Services Supply, Demand and Key Producers, 2026-2032
The global Blood Proteomics Services market size is expected to reach $ 1774 million by 2032, rising at a market growth of 11.6% CAGR during the forecast period (2026-2032).
Blood Proteomics Services refer to specialized research services that utilize advanced proteomics technologies to systematically identify, quantify, and interpret proteins from blood-derived biological samples, including plasma, serum, whole blood, and peripheral blood cells.
By analyzing circulating proteins, blood proteomics provides comprehensive insights into physiological conditions, disease progression, therapeutic responses, and biomarker discovery. Compared with genomics and transcriptomics, blood proteomics directly measures functional molecules that execute biological activities, making it highly valuable for understanding disease phenotypes and developing precision medicine solutions.
Blood Proteomics Services typically integrate high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), multiplex immunoassays, proximity extension assays (PEA), and aptamer-based protein profiling technologies. These services cover the complete workflow from blood sample preparation, protein extraction, analytical detection, quantitative profiling, computational analysis, biomarker identification, and biological interpretation.
Currently, blood proteomics services are widely applied in biomarker discovery, clinical trial support, drug mechanism studies, population-scale health research, oncology, cardiovascular disease research, neurological disorders, autoimmune diseases, and precision medicine. With advances in artificial intelligence, large-scale biobanks, and multi-omics integration, blood proteomics has become a critical platform connecting biomedical research with clinical translation.
Blood Proteomics Services primarily operate under a technology-driven CRO model combining advanced analytical platforms, specialized laboratory expertise, and bioinformatics capabilities.
Service providers typically establish integrated infrastructure including mass spectrometry platforms, automated sample preparation systems, protein profiling technologies, and computational analysis pipelines. Typical workflows include study design, blood sample quality control, plasma/serum preparation, depletion of high-abundance proteins, enzymatic digestion, mass spectrometry or affinity-based detection, data processing, statistical analysis, biomarker discovery, and final reporting.
The upstream value chain includes mass spectrometry manufacturers, chromatography suppliers, antibody and reagent providers, aptamer technology companies, bioinformatics software suppliers, and laboratory consumable manufacturers. The midstream consists of proteomics CRO companies, clinical research service providers, and multi-omics analysis platforms. Downstream customers include pharmaceutical companies, biotechnology firms, academic institutions, hospitals, biobanks, and precision medicine organizations.
Blood Proteomics Services represent a high-value-added segment in life science research. Standardized plasma proteomics services generally achieve gross margins of approximately 40%-60%. Advanced services based on deep proteomics, DIA workflows, clinical cohorts, and drug discovery applications typically generate gross margins of 55%-75% due to higher equipment investment, analytical complexity, and data value. Companies with proprietary platforms, databases, computational capabilities, and pharmaceutical partnerships may achieve margins around 70%.
Blood Proteomics Services are becoming a strategic growth area in precision medicine and innovative drug development. As biomedical research moves from genomic information toward functional protein regulation, demand for circulating biomarkers, disease prediction, and treatment response analysis continues to increase.
By enabling large-scale profiling of circulating proteins, blood proteomics can identify disease-related molecular signals that are difficult to capture using traditional approaches. It provides new opportunities in cancer screening, immunotherapy, neurological research, and chronic disease management. The development of large-scale biobanks, artificial intelligence analytics, and multi-omics integration will further accelerate commercialization. Olink platforms have been adopted by pharmaceutical companies and research institutions worldwide to support proteomics research and translational applications.
The blood proteomics service market faces challenges including high analytical costs, extremely broad protein concentration ranges, difficulty detecting low-abundance proteins, and limited standardization among platforms.
High-abundance plasma proteins may interfere with the detection of disease-related low-abundance biomarkers, requiring advanced depletion strategies, deep mass spectrometry workflows, and highly sensitive detection technologies. In addition, complex proteomics datasets require advanced computational capabilities, creating significant entry barriers. Data standards, quality control, and regulatory requirements will become increasingly important as clinical applications expand.
Future demand for Blood Proteomics Services will increasingly focus on clinical translation, population-scale studies, and pharmaceutical applications.
Pharmaceutical companies will utilize blood proteomics for target discovery, mechanism-of-action studies, patient stratification, and companion diagnostic development. Biotechnology companies will increasingly rely on CRO providers to reduce infrastructure investment and accelerate innovation programs. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued growth of precision medicine and AI-driven life sciences, Blood Proteomics Services providers with high-throughput capabilities, advanced analytics, proprietary databases, and global delivery networks will gain stronger competitive positions in the future market.
Report Scope
This report studies the global Blood Proteomics Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Blood Proteomics Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood Proteomics Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Blood Proteomics Services total market, 2021-2032, (USD Million)
Global Blood Proteomics Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Blood Proteomics Services total market, key domestic companies, and share, (USD Million)
Global Blood Proteomics Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Blood Proteomics Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Blood Proteomics Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Blood Proteomics Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Olink (Thermo Fisher Scientific), SomaLogic (Illumina), Labcorp, BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Blood Proteomics Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Blood Proteomics Services Market, By Region:
1. How big is the global Blood Proteomics Services market?
2. What is the demand of the global Blood Proteomics Services market?
3. What is the year over year growth of the global Blood Proteomics Services market?
4. What is the total value of the global Blood Proteomics Services market?
5. Who are the Major Players in the global Blood Proteomics Services market?
6. What are the growth factors driving the market demand?
Blood Proteomics Services refer to specialized research services that utilize advanced proteomics technologies to systematically identify, quantify, and interpret proteins from blood-derived biological samples, including plasma, serum, whole blood, and peripheral blood cells.
By analyzing circulating proteins, blood proteomics provides comprehensive insights into physiological conditions, disease progression, therapeutic responses, and biomarker discovery. Compared with genomics and transcriptomics, blood proteomics directly measures functional molecules that execute biological activities, making it highly valuable for understanding disease phenotypes and developing precision medicine solutions.
Blood Proteomics Services typically integrate high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), multiplex immunoassays, proximity extension assays (PEA), and aptamer-based protein profiling technologies. These services cover the complete workflow from blood sample preparation, protein extraction, analytical detection, quantitative profiling, computational analysis, biomarker identification, and biological interpretation.
Currently, blood proteomics services are widely applied in biomarker discovery, clinical trial support, drug mechanism studies, population-scale health research, oncology, cardiovascular disease research, neurological disorders, autoimmune diseases, and precision medicine. With advances in artificial intelligence, large-scale biobanks, and multi-omics integration, blood proteomics has become a critical platform connecting biomedical research with clinical translation.
Blood Proteomics Services primarily operate under a technology-driven CRO model combining advanced analytical platforms, specialized laboratory expertise, and bioinformatics capabilities.
Service providers typically establish integrated infrastructure including mass spectrometry platforms, automated sample preparation systems, protein profiling technologies, and computational analysis pipelines. Typical workflows include study design, blood sample quality control, plasma/serum preparation, depletion of high-abundance proteins, enzymatic digestion, mass spectrometry or affinity-based detection, data processing, statistical analysis, biomarker discovery, and final reporting.
The upstream value chain includes mass spectrometry manufacturers, chromatography suppliers, antibody and reagent providers, aptamer technology companies, bioinformatics software suppliers, and laboratory consumable manufacturers. The midstream consists of proteomics CRO companies, clinical research service providers, and multi-omics analysis platforms. Downstream customers include pharmaceutical companies, biotechnology firms, academic institutions, hospitals, biobanks, and precision medicine organizations.
Blood Proteomics Services represent a high-value-added segment in life science research. Standardized plasma proteomics services generally achieve gross margins of approximately 40%-60%. Advanced services based on deep proteomics, DIA workflows, clinical cohorts, and drug discovery applications typically generate gross margins of 55%-75% due to higher equipment investment, analytical complexity, and data value. Companies with proprietary platforms, databases, computational capabilities, and pharmaceutical partnerships may achieve margins around 70%.
Blood Proteomics Services are becoming a strategic growth area in precision medicine and innovative drug development. As biomedical research moves from genomic information toward functional protein regulation, demand for circulating biomarkers, disease prediction, and treatment response analysis continues to increase.
By enabling large-scale profiling of circulating proteins, blood proteomics can identify disease-related molecular signals that are difficult to capture using traditional approaches. It provides new opportunities in cancer screening, immunotherapy, neurological research, and chronic disease management. The development of large-scale biobanks, artificial intelligence analytics, and multi-omics integration will further accelerate commercialization. Olink platforms have been adopted by pharmaceutical companies and research institutions worldwide to support proteomics research and translational applications.
The blood proteomics service market faces challenges including high analytical costs, extremely broad protein concentration ranges, difficulty detecting low-abundance proteins, and limited standardization among platforms.
High-abundance plasma proteins may interfere with the detection of disease-related low-abundance biomarkers, requiring advanced depletion strategies, deep mass spectrometry workflows, and highly sensitive detection technologies. In addition, complex proteomics datasets require advanced computational capabilities, creating significant entry barriers. Data standards, quality control, and regulatory requirements will become increasingly important as clinical applications expand.
Future demand for Blood Proteomics Services will increasingly focus on clinical translation, population-scale studies, and pharmaceutical applications.
Pharmaceutical companies will utilize blood proteomics for target discovery, mechanism-of-action studies, patient stratification, and companion diagnostic development. Biotechnology companies will increasingly rely on CRO providers to reduce infrastructure investment and accelerate innovation programs. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued growth of precision medicine and AI-driven life sciences, Blood Proteomics Services providers with high-throughput capabilities, advanced analytics, proprietary databases, and global delivery networks will gain stronger competitive positions in the future market.
Report Scope
This report studies the global Blood Proteomics Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Blood Proteomics Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood Proteomics Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Blood Proteomics Services total market, 2021-2032, (USD Million)
Global Blood Proteomics Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Blood Proteomics Services total market, key domestic companies, and share, (USD Million)
Global Blood Proteomics Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Blood Proteomics Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Blood Proteomics Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Blood Proteomics Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Olink (Thermo Fisher Scientific), SomaLogic (Illumina), Labcorp, BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Blood Proteomics Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Blood Proteomics Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Blood Proteomics
- Blood Modification Proteomics
- Olink (Targeted) Proteomics
- Universities and Research Institutes
- Hospitals
- Pharmaceutical Companies
- Others
- Oncology
- Cardiovascular
- Agriculture
- Neuroscience
- Other
- Disease Biomarker Research
- Drug Development
- Clinical Research
- Others
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- Labcorp
- BostonGene
- CellCarta
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Biognosys
- Discovery Life Sciences
- Firalis Molecular Precision
- Cell Signaling Technology (CST)
- Sampled (Infinity Biologix)
- APTBIO
- Sinotech Genomics
- Biodesix
- Panome Bio
- Novogene
- PTM BIO
- BGI Genomics
- Evotec
- Metware Biotechnology
- MRM Proteomics
- Lc-Bio Technologies
- Eurofins Scientific
- MtoZ-Biolabs
- Creative Proteomics
- Macrogen
- TATAA Biocenter
- OmicScouts (Momentum Biotechnologies)
- Precision Biomarker Laboratories (PBL)
- Shanghai OE Biotech
- RxCelerate
- Proteomics International
- Proteome Sciences
- Westlake Omics
- Crown Bioscience
- VProteomics
- Shanghai Majorbio Bio-Pharm
- Applied Biomics
- Sapient Bioanalytics
- Allumiqs
- MS Bioworks
- Shanghai Bioprofile
- Cosmos Wisdom
1. How big is the global Blood Proteomics Services market?
2. What is the demand of the global Blood Proteomics Services market?
3. What is the year over year growth of the global Blood Proteomics Services market?
4. What is the total value of the global Blood Proteomics Services market?
5. Who are the Major Players in the global Blood Proteomics Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Blood Proteomics Services Introduction
1.2 World Blood Proteomics Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Blood Proteomics Services Total Market by Region (by Headquarter Location)
1.3.1 World Blood Proteomics Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.3 China Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.4 Europe Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.5 Japan Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.6 South Korea Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.8 India Based Company Blood Proteomics Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Blood Proteomics Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Blood Proteomics Services Consumption Value (2021-2032)
2.2 World Blood Proteomics Services Consumption Value by Region
2.2.1 World Blood Proteomics Services Consumption Value by Region (2021-2026)
2.2.2 World Blood Proteomics Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Blood Proteomics Services Consumption Value (2021-2032)
2.4 China Blood Proteomics Services Consumption Value (2021-2032)
2.5 Europe Blood Proteomics Services Consumption Value (2021-2032)
2.6 Japan Blood Proteomics Services Consumption Value (2021-2032)
2.7 South Korea Blood Proteomics Services Consumption Value (2021-2032)
2.8 ASEAN Blood Proteomics Services Consumption Value (2021-2032)
2.9 India Blood Proteomics Services Consumption Value (2021-2032)
3 WORLD BLOOD PROTEOMICS SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Blood Proteomics Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Blood Proteomics Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Blood Proteomics Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Blood Proteomics Services in 2025
3.3 Blood Proteomics Services Company Evaluation Quadrant
3.4 Blood Proteomics Services Market: Overall Company Footprint Analysis
3.4.1 Blood Proteomics Services Market: Region Footprint
3.4.2 Blood Proteomics Services Market: Company Product Type Footprint
3.4.3 Blood Proteomics Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Blood Proteomics Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Blood Proteomics Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Blood Proteomics Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Blood Proteomics Services Consumption Value Comparison
4.2.1 United States VS China: Blood Proteomics Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Blood Proteomics Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Blood Proteomics Services Companies and Market Share, 2021-2026
4.3.1 United States Based Blood Proteomics Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Blood Proteomics Services Revenue, (2021-2026)
4.4 China Based Companies Blood Proteomics Services Revenue and Market Share, 2021-2026
4.4.1 China Based Blood Proteomics Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Blood Proteomics Services Revenue, (2021-2026)
4.5 Rest of World Based Blood Proteomics Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Blood Proteomics Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Blood Proteomics Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Blood Proteomics Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood Proteomics
5.2.2 Blood Modification Proteomics
5.2.3 Olink (Targeted) Proteomics
5.3 Market Segment by Type
5.3.1 World Blood Proteomics Services Market Size by Type (2021-2026)
5.3.2 World Blood Proteomics Services Market Size by Type (2027-2032)
5.3.3 World Blood Proteomics Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY END USER
6.1 World Blood Proteomics Services Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Universities and Research Institutes
6.2.2 Hospitals
6.2.3 Pharmaceutical Companies
6.2.4 Others
6.3 Market Segment by End User
6.3.1 World Blood Proteomics Services Market Size by End User (2021-2026)
6.3.2 World Blood Proteomics Services Market Size by End User (2027-2032)
6.3.3 World Blood Proteomics Services Market Size Market Share by End User (2027-2032)
7 MARKET ANALYSIS BY RESEARCH AREAS
7.1 World Blood Proteomics Services Market Size Overview by Research Areas: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Research Areas
7.2.1 Oncology
7.2.2 Cardiovascular
7.2.3 Agriculture
7.2.4 Neuroscience
7.2.5 Other
7.3 Market Segment by Research Areas
7.3.1 World Blood Proteomics Services Market Size by Research Areas (2021-2026)
7.3.2 World Blood Proteomics Services Market Size by Research Areas (2027-2032)
7.3.3 World Blood Proteomics Services Market Size Market Share by Research Areas (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Blood Proteomics Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Disease Biomarker Research
8.2.2 Drug Development
8.2.3 Clinical Research
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Blood Proteomics Services Market Size by Application (2021-2026)
8.3.2 World Blood Proteomics Services Market Size by Application (2027-2032)
8.3.3 World Blood Proteomics Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Olink (Thermo Fisher Scientific)
9.1.1 Olink (Thermo Fisher Scientific) Details
9.1.2 Olink (Thermo Fisher Scientific) Major Business
9.1.3 Olink (Thermo Fisher Scientific) Blood Proteomics Services Product and Services
9.1.4 Olink (Thermo Fisher Scientific) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Olink (Thermo Fisher Scientific) Recent Developments/Updates
9.1.6 Olink (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
9.2 SomaLogic (Illumina)
9.2.1 SomaLogic (Illumina) Details
9.2.2 SomaLogic (Illumina) Major Business
9.2.3 SomaLogic (Illumina) Blood Proteomics Services Product and Services
9.2.4 SomaLogic (Illumina) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 SomaLogic (Illumina) Recent Developments/Updates
9.2.6 SomaLogic (Illumina) Competitive Strengths & Weaknesses
9.3 Labcorp
9.3.1 Labcorp Details
9.3.2 Labcorp Major Business
9.3.3 Labcorp Blood Proteomics Services Product and Services
9.3.4 Labcorp Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Labcorp Recent Developments/Updates
9.3.6 Labcorp Competitive Strengths & Weaknesses
9.4 BostonGene
9.4.1 BostonGene Details
9.4.2 BostonGene Major Business
9.4.3 BostonGene Blood Proteomics Services Product and Services
9.4.4 BostonGene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 BostonGene Recent Developments/Updates
9.4.6 BostonGene Competitive Strengths & Weaknesses
9.5 CellCarta
9.5.1 CellCarta Details
9.5.2 CellCarta Major Business
9.5.3 CellCarta Blood Proteomics Services Product and Services
9.5.4 CellCarta Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 CellCarta Recent Developments/Updates
9.5.6 CellCarta Competitive Strengths & Weaknesses
9.6 GENEWIZ (Azenta Life Sciences)
9.6.1 GENEWIZ (Azenta Life Sciences) Details
9.6.2 GENEWIZ (Azenta Life Sciences) Major Business
9.6.3 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product and Services
9.6.4 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments/Updates
9.6.6 GENEWIZ (Azenta Life Sciences) Competitive Strengths & Weaknesses
9.7 CDI Labs
9.7.1 CDI Labs Details
9.7.2 CDI Labs Major Business
9.7.3 CDI Labs Blood Proteomics Services Product and Services
9.7.4 CDI Labs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CDI Labs Recent Developments/Updates
9.7.6 CDI Labs Competitive Strengths & Weaknesses
9.8 Biognosys
9.8.1 Biognosys Details
9.8.2 Biognosys Major Business
9.8.3 Biognosys Blood Proteomics Services Product and Services
9.8.4 Biognosys Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Biognosys Recent Developments/Updates
9.8.6 Biognosys Competitive Strengths & Weaknesses
9.9 Discovery Life Sciences
9.9.1 Discovery Life Sciences Details
9.9.2 Discovery Life Sciences Major Business
9.9.3 Discovery Life Sciences Blood Proteomics Services Product and Services
9.9.4 Discovery Life Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Discovery Life Sciences Recent Developments/Updates
9.9.6 Discovery Life Sciences Competitive Strengths & Weaknesses
9.10 Firalis Molecular Precision
9.10.1 Firalis Molecular Precision Details
9.10.2 Firalis Molecular Precision Major Business
9.10.3 Firalis Molecular Precision Blood Proteomics Services Product and Services
9.10.4 Firalis Molecular Precision Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Firalis Molecular Precision Recent Developments/Updates
9.10.6 Firalis Molecular Precision Competitive Strengths & Weaknesses
9.11 Cell Signaling Technology (CST)
9.11.1 Cell Signaling Technology (CST) Details
9.11.2 Cell Signaling Technology (CST) Major Business
9.11.3 Cell Signaling Technology (CST) Blood Proteomics Services Product and Services
9.11.4 Cell Signaling Technology (CST) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cell Signaling Technology (CST) Recent Developments/Updates
9.11.6 Cell Signaling Technology (CST) Competitive Strengths & Weaknesses
9.12 Sampled (Infinity Biologix)
9.12.1 Sampled (Infinity Biologix) Details
9.12.2 Sampled (Infinity Biologix) Major Business
9.12.3 Sampled (Infinity Biologix) Blood Proteomics Services Product and Services
9.12.4 Sampled (Infinity Biologix) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Sampled (Infinity Biologix) Recent Developments/Updates
9.12.6 Sampled (Infinity Biologix) Competitive Strengths & Weaknesses
9.13 APTBIO
9.13.1 APTBIO Details
9.13.2 APTBIO Major Business
9.13.3 APTBIO Blood Proteomics Services Product and Services
9.13.4 APTBIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 APTBIO Recent Developments/Updates
9.13.6 APTBIO Competitive Strengths & Weaknesses
9.14 Sinotech Genomics
9.14.1 Sinotech Genomics Details
9.14.2 Sinotech Genomics Major Business
9.14.3 Sinotech Genomics Blood Proteomics Services Product and Services
9.14.4 Sinotech Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Sinotech Genomics Recent Developments/Updates
9.14.6 Sinotech Genomics Competitive Strengths & Weaknesses
9.15 Biodesix
9.15.1 Biodesix Details
9.15.2 Biodesix Major Business
9.15.3 Biodesix Blood Proteomics Services Product and Services
9.15.4 Biodesix Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Biodesix Recent Developments/Updates
9.15.6 Biodesix Competitive Strengths & Weaknesses
9.16 Panome Bio
9.16.1 Panome Bio Details
9.16.2 Panome Bio Major Business
9.16.3 Panome Bio Blood Proteomics Services Product and Services
9.16.4 Panome Bio Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Panome Bio Recent Developments/Updates
9.16.6 Panome Bio Competitive Strengths & Weaknesses
9.17 Novogene
9.17.1 Novogene Details
9.17.2 Novogene Major Business
9.17.3 Novogene Blood Proteomics Services Product and Services
9.17.4 Novogene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Novogene Recent Developments/Updates
9.17.6 Novogene Competitive Strengths & Weaknesses
9.18 PTM BIO
9.18.1 PTM BIO Details
9.18.2 PTM BIO Major Business
9.18.3 PTM BIO Blood Proteomics Services Product and Services
9.18.4 PTM BIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 PTM BIO Recent Developments/Updates
9.18.6 PTM BIO Competitive Strengths & Weaknesses
9.19 BGI Genomics
9.19.1 BGI Genomics Details
9.19.2 BGI Genomics Major Business
9.19.3 BGI Genomics Blood Proteomics Services Product and Services
9.19.4 BGI Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 BGI Genomics Recent Developments/Updates
9.19.6 BGI Genomics Competitive Strengths & Weaknesses
9.20 Evotec
9.20.1 Evotec Details
9.20.2 Evotec Major Business
9.20.3 Evotec Blood Proteomics Services Product and Services
9.20.4 Evotec Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Evotec Recent Developments/Updates
9.20.6 Evotec Competitive Strengths & Weaknesses
9.21 Metware Biotechnology
9.21.1 Metware Biotechnology Details
9.21.2 Metware Biotechnology Major Business
9.21.3 Metware Biotechnology Blood Proteomics Services Product and Services
9.21.4 Metware Biotechnology Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Metware Biotechnology Recent Developments/Updates
9.21.6 Metware Biotechnology Competitive Strengths & Weaknesses
9.22 MRM Proteomics
9.22.1 MRM Proteomics Details
9.22.2 MRM Proteomics Major Business
9.22.3 MRM Proteomics Blood Proteomics Services Product and Services
9.22.4 MRM Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 MRM Proteomics Recent Developments/Updates
9.22.6 MRM Proteomics Competitive Strengths & Weaknesses
9.23 Lc-Bio Technologies
9.23.1 Lc-Bio Technologies Details
9.23.2 Lc-Bio Technologies Major Business
9.23.3 Lc-Bio Technologies Blood Proteomics Services Product and Services
9.23.4 Lc-Bio Technologies Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Lc-Bio Technologies Recent Developments/Updates
9.23.6 Lc-Bio Technologies Competitive Strengths & Weaknesses
9.24 Eurofins Scientific
9.24.1 Eurofins Scientific Details
9.24.2 Eurofins Scientific Major Business
9.24.3 Eurofins Scientific Blood Proteomics Services Product and Services
9.24.4 Eurofins Scientific Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Eurofins Scientific Recent Developments/Updates
9.24.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.25 MtoZ-Biolabs
9.25.1 MtoZ-Biolabs Details
9.25.2 MtoZ-Biolabs Major Business
9.25.3 MtoZ-Biolabs Blood Proteomics Services Product and Services
9.25.4 MtoZ-Biolabs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 MtoZ-Biolabs Recent Developments/Updates
9.25.6 MtoZ-Biolabs Competitive Strengths & Weaknesses
9.26 Creative Proteomics
9.26.1 Creative Proteomics Details
9.26.2 Creative Proteomics Major Business
9.26.3 Creative Proteomics Blood Proteomics Services Product and Services
9.26.4 Creative Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Creative Proteomics Recent Developments/Updates
9.26.6 Creative Proteomics Competitive Strengths & Weaknesses
9.27 Macrogen
9.27.1 Macrogen Details
9.27.2 Macrogen Major Business
9.27.3 Macrogen Blood Proteomics Services Product and Services
9.27.4 Macrogen Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Macrogen Recent Developments/Updates
9.27.6 Macrogen Competitive Strengths & Weaknesses
9.28 TATAA Biocenter
9.28.1 TATAA Biocenter Details
9.28.2 TATAA Biocenter Major Business
9.28.3 TATAA Biocenter Blood Proteomics Services Product and Services
9.28.4 TATAA Biocenter Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 TATAA Biocenter Recent Developments/Updates
9.28.6 TATAA Biocenter Competitive Strengths & Weaknesses
9.29 OmicScouts (Momentum Biotechnologies)
9.29.1 OmicScouts (Momentum Biotechnologies) Details
9.29.2 OmicScouts (Momentum Biotechnologies) Major Business
9.29.3 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product and Services
9.29.4 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments/Updates
9.29.6 OmicScouts (Momentum Biotechnologies) Competitive Strengths & Weaknesses
9.30 Precision Biomarker Laboratories (PBL)
9.30.1 Precision Biomarker Laboratories (PBL) Details
9.30.2 Precision Biomarker Laboratories (PBL) Major Business
9.30.3 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product and Services
9.30.4 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Precision Biomarker Laboratories (PBL) Recent Developments/Updates
9.30.6 Precision Biomarker Laboratories (PBL) Competitive Strengths & Weaknesses
9.31 Shanghai OE Biotech
9.31.1 Shanghai OE Biotech Details
9.31.2 Shanghai OE Biotech Major Business
9.31.3 Shanghai OE Biotech Blood Proteomics Services Product and Services
9.31.4 Shanghai OE Biotech Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Shanghai OE Biotech Recent Developments/Updates
9.31.6 Shanghai OE Biotech Competitive Strengths & Weaknesses
9.32 RxCelerate
9.32.1 RxCelerate Details
9.32.2 RxCelerate Major Business
9.32.3 RxCelerate Blood Proteomics Services Product and Services
9.32.4 RxCelerate Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 RxCelerate Recent Developments/Updates
9.32.6 RxCelerate Competitive Strengths & Weaknesses
9.33 Proteomics International
9.33.1 Proteomics International Details
9.33.2 Proteomics International Major Business
9.33.3 Proteomics International Blood Proteomics Services Product and Services
9.33.4 Proteomics International Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Proteomics International Recent Developments/Updates
9.33.6 Proteomics International Competitive Strengths & Weaknesses
9.34 Proteome Sciences
9.34.1 Proteome Sciences Details
9.34.2 Proteome Sciences Major Business
9.34.3 Proteome Sciences Blood Proteomics Services Product and Services
9.34.4 Proteome Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 Proteome Sciences Recent Developments/Updates
9.34.6 Proteome Sciences Competitive Strengths & Weaknesses
9.35 Westlake Omics
9.35.1 Westlake Omics Details
9.35.2 Westlake Omics Major Business
9.35.3 Westlake Omics Blood Proteomics Services Product and Services
9.35.4 Westlake Omics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 Westlake Omics Recent Developments/Updates
9.35.6 Westlake Omics Competitive Strengths & Weaknesses
9.36 Crown Bioscience
9.36.1 Crown Bioscience Details
9.36.2 Crown Bioscience Major Business
9.36.3 Crown Bioscience Blood Proteomics Services Product and Services
9.36.4 Crown Bioscience Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 Crown Bioscience Recent Developments/Updates
9.36.6 Crown Bioscience Competitive Strengths & Weaknesses
9.37 VProteomics
9.37.1 VProteomics Details
9.37.2 VProteomics Major Business
9.37.3 VProteomics Blood Proteomics Services Product and Services
9.37.4 VProteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 VProteomics Recent Developments/Updates
9.37.6 VProteomics Competitive Strengths & Weaknesses
9.38 Shanghai Majorbio Bio-Pharm
9.38.1 Shanghai Majorbio Bio-Pharm Details
9.38.2 Shanghai Majorbio Bio-Pharm Major Business
9.38.3 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product and Services
9.38.4 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Shanghai Majorbio Bio-Pharm Recent Developments/Updates
9.38.6 Shanghai Majorbio Bio-Pharm Competitive Strengths & Weaknesses
9.39 Applied Biomics
9.39.1 Applied Biomics Details
9.39.2 Applied Biomics Major Business
9.39.3 Applied Biomics Blood Proteomics Services Product and Services
9.39.4 Applied Biomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Applied Biomics Recent Developments/Updates
9.39.6 Applied Biomics Competitive Strengths & Weaknesses
9.40 Sapient Bioanalytics
9.40.1 Sapient Bioanalytics Details
9.40.2 Sapient Bioanalytics Major Business
9.40.3 Sapient Bioanalytics Blood Proteomics Services Product and Services
9.40.4 Sapient Bioanalytics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.40.5 Sapient Bioanalytics Recent Developments/Updates
9.40.6 Sapient Bioanalytics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Blood Proteomics Services Industry Chain
10.2 Blood Proteomics Services Upstream Analysis
10.3 Blood Proteomics Services Midstream Analysis
10.4 Blood Proteomics Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Blood Proteomics Services Introduction
1.2 World Blood Proteomics Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Blood Proteomics Services Total Market by Region (by Headquarter Location)
1.3.1 World Blood Proteomics Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.3 China Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.4 Europe Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.5 Japan Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.6 South Korea Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Blood Proteomics Services Revenue (2021-2032)
1.3.8 India Based Company Blood Proteomics Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Blood Proteomics Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Blood Proteomics Services Consumption Value (2021-2032)
2.2 World Blood Proteomics Services Consumption Value by Region
2.2.1 World Blood Proteomics Services Consumption Value by Region (2021-2026)
2.2.2 World Blood Proteomics Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Blood Proteomics Services Consumption Value (2021-2032)
2.4 China Blood Proteomics Services Consumption Value (2021-2032)
2.5 Europe Blood Proteomics Services Consumption Value (2021-2032)
2.6 Japan Blood Proteomics Services Consumption Value (2021-2032)
2.7 South Korea Blood Proteomics Services Consumption Value (2021-2032)
2.8 ASEAN Blood Proteomics Services Consumption Value (2021-2032)
2.9 India Blood Proteomics Services Consumption Value (2021-2032)
3 WORLD BLOOD PROTEOMICS SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Blood Proteomics Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Blood Proteomics Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Blood Proteomics Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Blood Proteomics Services in 2025
3.3 Blood Proteomics Services Company Evaluation Quadrant
3.4 Blood Proteomics Services Market: Overall Company Footprint Analysis
3.4.1 Blood Proteomics Services Market: Region Footprint
3.4.2 Blood Proteomics Services Market: Company Product Type Footprint
3.4.3 Blood Proteomics Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Blood Proteomics Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Blood Proteomics Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Blood Proteomics Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Blood Proteomics Services Consumption Value Comparison
4.2.1 United States VS China: Blood Proteomics Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Blood Proteomics Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Blood Proteomics Services Companies and Market Share, 2021-2026
4.3.1 United States Based Blood Proteomics Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Blood Proteomics Services Revenue, (2021-2026)
4.4 China Based Companies Blood Proteomics Services Revenue and Market Share, 2021-2026
4.4.1 China Based Blood Proteomics Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Blood Proteomics Services Revenue, (2021-2026)
4.5 Rest of World Based Blood Proteomics Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Blood Proteomics Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Blood Proteomics Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Blood Proteomics Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood Proteomics
5.2.2 Blood Modification Proteomics
5.2.3 Olink (Targeted) Proteomics
5.3 Market Segment by Type
5.3.1 World Blood Proteomics Services Market Size by Type (2021-2026)
5.3.2 World Blood Proteomics Services Market Size by Type (2027-2032)
5.3.3 World Blood Proteomics Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY END USER
6.1 World Blood Proteomics Services Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Universities and Research Institutes
6.2.2 Hospitals
6.2.3 Pharmaceutical Companies
6.2.4 Others
6.3 Market Segment by End User
6.3.1 World Blood Proteomics Services Market Size by End User (2021-2026)
6.3.2 World Blood Proteomics Services Market Size by End User (2027-2032)
6.3.3 World Blood Proteomics Services Market Size Market Share by End User (2027-2032)
7 MARKET ANALYSIS BY RESEARCH AREAS
7.1 World Blood Proteomics Services Market Size Overview by Research Areas: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Research Areas
7.2.1 Oncology
7.2.2 Cardiovascular
7.2.3 Agriculture
7.2.4 Neuroscience
7.2.5 Other
7.3 Market Segment by Research Areas
7.3.1 World Blood Proteomics Services Market Size by Research Areas (2021-2026)
7.3.2 World Blood Proteomics Services Market Size by Research Areas (2027-2032)
7.3.3 World Blood Proteomics Services Market Size Market Share by Research Areas (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Blood Proteomics Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Disease Biomarker Research
8.2.2 Drug Development
8.2.3 Clinical Research
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Blood Proteomics Services Market Size by Application (2021-2026)
8.3.2 World Blood Proteomics Services Market Size by Application (2027-2032)
8.3.3 World Blood Proteomics Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Olink (Thermo Fisher Scientific)
9.1.1 Olink (Thermo Fisher Scientific) Details
9.1.2 Olink (Thermo Fisher Scientific) Major Business
9.1.3 Olink (Thermo Fisher Scientific) Blood Proteomics Services Product and Services
9.1.4 Olink (Thermo Fisher Scientific) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Olink (Thermo Fisher Scientific) Recent Developments/Updates
9.1.6 Olink (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
9.2 SomaLogic (Illumina)
9.2.1 SomaLogic (Illumina) Details
9.2.2 SomaLogic (Illumina) Major Business
9.2.3 SomaLogic (Illumina) Blood Proteomics Services Product and Services
9.2.4 SomaLogic (Illumina) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 SomaLogic (Illumina) Recent Developments/Updates
9.2.6 SomaLogic (Illumina) Competitive Strengths & Weaknesses
9.3 Labcorp
9.3.1 Labcorp Details
9.3.2 Labcorp Major Business
9.3.3 Labcorp Blood Proteomics Services Product and Services
9.3.4 Labcorp Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Labcorp Recent Developments/Updates
9.3.6 Labcorp Competitive Strengths & Weaknesses
9.4 BostonGene
9.4.1 BostonGene Details
9.4.2 BostonGene Major Business
9.4.3 BostonGene Blood Proteomics Services Product and Services
9.4.4 BostonGene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 BostonGene Recent Developments/Updates
9.4.6 BostonGene Competitive Strengths & Weaknesses
9.5 CellCarta
9.5.1 CellCarta Details
9.5.2 CellCarta Major Business
9.5.3 CellCarta Blood Proteomics Services Product and Services
9.5.4 CellCarta Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 CellCarta Recent Developments/Updates
9.5.6 CellCarta Competitive Strengths & Weaknesses
9.6 GENEWIZ (Azenta Life Sciences)
9.6.1 GENEWIZ (Azenta Life Sciences) Details
9.6.2 GENEWIZ (Azenta Life Sciences) Major Business
9.6.3 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product and Services
9.6.4 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments/Updates
9.6.6 GENEWIZ (Azenta Life Sciences) Competitive Strengths & Weaknesses
9.7 CDI Labs
9.7.1 CDI Labs Details
9.7.2 CDI Labs Major Business
9.7.3 CDI Labs Blood Proteomics Services Product and Services
9.7.4 CDI Labs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CDI Labs Recent Developments/Updates
9.7.6 CDI Labs Competitive Strengths & Weaknesses
9.8 Biognosys
9.8.1 Biognosys Details
9.8.2 Biognosys Major Business
9.8.3 Biognosys Blood Proteomics Services Product and Services
9.8.4 Biognosys Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Biognosys Recent Developments/Updates
9.8.6 Biognosys Competitive Strengths & Weaknesses
9.9 Discovery Life Sciences
9.9.1 Discovery Life Sciences Details
9.9.2 Discovery Life Sciences Major Business
9.9.3 Discovery Life Sciences Blood Proteomics Services Product and Services
9.9.4 Discovery Life Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Discovery Life Sciences Recent Developments/Updates
9.9.6 Discovery Life Sciences Competitive Strengths & Weaknesses
9.10 Firalis Molecular Precision
9.10.1 Firalis Molecular Precision Details
9.10.2 Firalis Molecular Precision Major Business
9.10.3 Firalis Molecular Precision Blood Proteomics Services Product and Services
9.10.4 Firalis Molecular Precision Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Firalis Molecular Precision Recent Developments/Updates
9.10.6 Firalis Molecular Precision Competitive Strengths & Weaknesses
9.11 Cell Signaling Technology (CST)
9.11.1 Cell Signaling Technology (CST) Details
9.11.2 Cell Signaling Technology (CST) Major Business
9.11.3 Cell Signaling Technology (CST) Blood Proteomics Services Product and Services
9.11.4 Cell Signaling Technology (CST) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cell Signaling Technology (CST) Recent Developments/Updates
9.11.6 Cell Signaling Technology (CST) Competitive Strengths & Weaknesses
9.12 Sampled (Infinity Biologix)
9.12.1 Sampled (Infinity Biologix) Details
9.12.2 Sampled (Infinity Biologix) Major Business
9.12.3 Sampled (Infinity Biologix) Blood Proteomics Services Product and Services
9.12.4 Sampled (Infinity Biologix) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Sampled (Infinity Biologix) Recent Developments/Updates
9.12.6 Sampled (Infinity Biologix) Competitive Strengths & Weaknesses
9.13 APTBIO
9.13.1 APTBIO Details
9.13.2 APTBIO Major Business
9.13.3 APTBIO Blood Proteomics Services Product and Services
9.13.4 APTBIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 APTBIO Recent Developments/Updates
9.13.6 APTBIO Competitive Strengths & Weaknesses
9.14 Sinotech Genomics
9.14.1 Sinotech Genomics Details
9.14.2 Sinotech Genomics Major Business
9.14.3 Sinotech Genomics Blood Proteomics Services Product and Services
9.14.4 Sinotech Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Sinotech Genomics Recent Developments/Updates
9.14.6 Sinotech Genomics Competitive Strengths & Weaknesses
9.15 Biodesix
9.15.1 Biodesix Details
9.15.2 Biodesix Major Business
9.15.3 Biodesix Blood Proteomics Services Product and Services
9.15.4 Biodesix Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Biodesix Recent Developments/Updates
9.15.6 Biodesix Competitive Strengths & Weaknesses
9.16 Panome Bio
9.16.1 Panome Bio Details
9.16.2 Panome Bio Major Business
9.16.3 Panome Bio Blood Proteomics Services Product and Services
9.16.4 Panome Bio Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Panome Bio Recent Developments/Updates
9.16.6 Panome Bio Competitive Strengths & Weaknesses
9.17 Novogene
9.17.1 Novogene Details
9.17.2 Novogene Major Business
9.17.3 Novogene Blood Proteomics Services Product and Services
9.17.4 Novogene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Novogene Recent Developments/Updates
9.17.6 Novogene Competitive Strengths & Weaknesses
9.18 PTM BIO
9.18.1 PTM BIO Details
9.18.2 PTM BIO Major Business
9.18.3 PTM BIO Blood Proteomics Services Product and Services
9.18.4 PTM BIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 PTM BIO Recent Developments/Updates
9.18.6 PTM BIO Competitive Strengths & Weaknesses
9.19 BGI Genomics
9.19.1 BGI Genomics Details
9.19.2 BGI Genomics Major Business
9.19.3 BGI Genomics Blood Proteomics Services Product and Services
9.19.4 BGI Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 BGI Genomics Recent Developments/Updates
9.19.6 BGI Genomics Competitive Strengths & Weaknesses
9.20 Evotec
9.20.1 Evotec Details
9.20.2 Evotec Major Business
9.20.3 Evotec Blood Proteomics Services Product and Services
9.20.4 Evotec Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Evotec Recent Developments/Updates
9.20.6 Evotec Competitive Strengths & Weaknesses
9.21 Metware Biotechnology
9.21.1 Metware Biotechnology Details
9.21.2 Metware Biotechnology Major Business
9.21.3 Metware Biotechnology Blood Proteomics Services Product and Services
9.21.4 Metware Biotechnology Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Metware Biotechnology Recent Developments/Updates
9.21.6 Metware Biotechnology Competitive Strengths & Weaknesses
9.22 MRM Proteomics
9.22.1 MRM Proteomics Details
9.22.2 MRM Proteomics Major Business
9.22.3 MRM Proteomics Blood Proteomics Services Product and Services
9.22.4 MRM Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 MRM Proteomics Recent Developments/Updates
9.22.6 MRM Proteomics Competitive Strengths & Weaknesses
9.23 Lc-Bio Technologies
9.23.1 Lc-Bio Technologies Details
9.23.2 Lc-Bio Technologies Major Business
9.23.3 Lc-Bio Technologies Blood Proteomics Services Product and Services
9.23.4 Lc-Bio Technologies Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Lc-Bio Technologies Recent Developments/Updates
9.23.6 Lc-Bio Technologies Competitive Strengths & Weaknesses
9.24 Eurofins Scientific
9.24.1 Eurofins Scientific Details
9.24.2 Eurofins Scientific Major Business
9.24.3 Eurofins Scientific Blood Proteomics Services Product and Services
9.24.4 Eurofins Scientific Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Eurofins Scientific Recent Developments/Updates
9.24.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.25 MtoZ-Biolabs
9.25.1 MtoZ-Biolabs Details
9.25.2 MtoZ-Biolabs Major Business
9.25.3 MtoZ-Biolabs Blood Proteomics Services Product and Services
9.25.4 MtoZ-Biolabs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 MtoZ-Biolabs Recent Developments/Updates
9.25.6 MtoZ-Biolabs Competitive Strengths & Weaknesses
9.26 Creative Proteomics
9.26.1 Creative Proteomics Details
9.26.2 Creative Proteomics Major Business
9.26.3 Creative Proteomics Blood Proteomics Services Product and Services
9.26.4 Creative Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Creative Proteomics Recent Developments/Updates
9.26.6 Creative Proteomics Competitive Strengths & Weaknesses
9.27 Macrogen
9.27.1 Macrogen Details
9.27.2 Macrogen Major Business
9.27.3 Macrogen Blood Proteomics Services Product and Services
9.27.4 Macrogen Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Macrogen Recent Developments/Updates
9.27.6 Macrogen Competitive Strengths & Weaknesses
9.28 TATAA Biocenter
9.28.1 TATAA Biocenter Details
9.28.2 TATAA Biocenter Major Business
9.28.3 TATAA Biocenter Blood Proteomics Services Product and Services
9.28.4 TATAA Biocenter Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 TATAA Biocenter Recent Developments/Updates
9.28.6 TATAA Biocenter Competitive Strengths & Weaknesses
9.29 OmicScouts (Momentum Biotechnologies)
9.29.1 OmicScouts (Momentum Biotechnologies) Details
9.29.2 OmicScouts (Momentum Biotechnologies) Major Business
9.29.3 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product and Services
9.29.4 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments/Updates
9.29.6 OmicScouts (Momentum Biotechnologies) Competitive Strengths & Weaknesses
9.30 Precision Biomarker Laboratories (PBL)
9.30.1 Precision Biomarker Laboratories (PBL) Details
9.30.2 Precision Biomarker Laboratories (PBL) Major Business
9.30.3 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product and Services
9.30.4 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Precision Biomarker Laboratories (PBL) Recent Developments/Updates
9.30.6 Precision Biomarker Laboratories (PBL) Competitive Strengths & Weaknesses
9.31 Shanghai OE Biotech
9.31.1 Shanghai OE Biotech Details
9.31.2 Shanghai OE Biotech Major Business
9.31.3 Shanghai OE Biotech Blood Proteomics Services Product and Services
9.31.4 Shanghai OE Biotech Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Shanghai OE Biotech Recent Developments/Updates
9.31.6 Shanghai OE Biotech Competitive Strengths & Weaknesses
9.32 RxCelerate
9.32.1 RxCelerate Details
9.32.2 RxCelerate Major Business
9.32.3 RxCelerate Blood Proteomics Services Product and Services
9.32.4 RxCelerate Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 RxCelerate Recent Developments/Updates
9.32.6 RxCelerate Competitive Strengths & Weaknesses
9.33 Proteomics International
9.33.1 Proteomics International Details
9.33.2 Proteomics International Major Business
9.33.3 Proteomics International Blood Proteomics Services Product and Services
9.33.4 Proteomics International Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Proteomics International Recent Developments/Updates
9.33.6 Proteomics International Competitive Strengths & Weaknesses
9.34 Proteome Sciences
9.34.1 Proteome Sciences Details
9.34.2 Proteome Sciences Major Business
9.34.3 Proteome Sciences Blood Proteomics Services Product and Services
9.34.4 Proteome Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 Proteome Sciences Recent Developments/Updates
9.34.6 Proteome Sciences Competitive Strengths & Weaknesses
9.35 Westlake Omics
9.35.1 Westlake Omics Details
9.35.2 Westlake Omics Major Business
9.35.3 Westlake Omics Blood Proteomics Services Product and Services
9.35.4 Westlake Omics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 Westlake Omics Recent Developments/Updates
9.35.6 Westlake Omics Competitive Strengths & Weaknesses
9.36 Crown Bioscience
9.36.1 Crown Bioscience Details
9.36.2 Crown Bioscience Major Business
9.36.3 Crown Bioscience Blood Proteomics Services Product and Services
9.36.4 Crown Bioscience Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 Crown Bioscience Recent Developments/Updates
9.36.6 Crown Bioscience Competitive Strengths & Weaknesses
9.37 VProteomics
9.37.1 VProteomics Details
9.37.2 VProteomics Major Business
9.37.3 VProteomics Blood Proteomics Services Product and Services
9.37.4 VProteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 VProteomics Recent Developments/Updates
9.37.6 VProteomics Competitive Strengths & Weaknesses
9.38 Shanghai Majorbio Bio-Pharm
9.38.1 Shanghai Majorbio Bio-Pharm Details
9.38.2 Shanghai Majorbio Bio-Pharm Major Business
9.38.3 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product and Services
9.38.4 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Shanghai Majorbio Bio-Pharm Recent Developments/Updates
9.38.6 Shanghai Majorbio Bio-Pharm Competitive Strengths & Weaknesses
9.39 Applied Biomics
9.39.1 Applied Biomics Details
9.39.2 Applied Biomics Major Business
9.39.3 Applied Biomics Blood Proteomics Services Product and Services
9.39.4 Applied Biomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Applied Biomics Recent Developments/Updates
9.39.6 Applied Biomics Competitive Strengths & Weaknesses
9.40 Sapient Bioanalytics
9.40.1 Sapient Bioanalytics Details
9.40.2 Sapient Bioanalytics Major Business
9.40.3 Sapient Bioanalytics Blood Proteomics Services Product and Services
9.40.4 Sapient Bioanalytics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
9.40.5 Sapient Bioanalytics Recent Developments/Updates
9.40.6 Sapient Bioanalytics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Blood Proteomics Services Industry Chain
10.2 Blood Proteomics Services Upstream Analysis
10.3 Blood Proteomics Services Midstream Analysis
10.4 Blood Proteomics Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Blood Proteomics Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Blood Proteomics Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Blood Proteomics Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Blood Proteomics Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Blood Proteomics Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Blood Proteomics Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Blood Proteomics Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Blood Proteomics Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Blood Proteomics Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Blood Proteomics Services Players in 2025
Table 12. World Blood Proteomics Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Blood Proteomics Services Company Evaluation Quadrant
Table 14. Head Office of Key Blood Proteomics Services Players
Table 15. Blood Proteomics Services Market: Company Product Type Footprint
Table 16. Blood Proteomics Services Market: Company Product Application Footprint
Table 17. Blood Proteomics Services Mergers & Acquisitions Activity
Table 18. United States VS China Blood Proteomics Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Blood Proteomics Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Blood Proteomics Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Blood Proteomics Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Blood Proteomics Services Revenue Market Share (2021-2026)
Table 23. China Based Blood Proteomics Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Blood Proteomics Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Blood Proteomics Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Blood Proteomics Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Blood Proteomics Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Blood Proteomics Services Revenue Market Share (2021-2026)
Table 29. World Blood Proteomics Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Blood Proteomics Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Blood Proteomics Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Blood Proteomics Services Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 33. World Blood Proteomics Services Market Size Value by End User (2021-2026) & (USD Million)
Table 34. World Blood Proteomics Services Market Size by End User (2027-2032) & (USD Million)
Table 35. World Blood Proteomics Services Market Size by Research Areas, (USD Million), 2021 & 2025 & 2032
Table 36. World Blood Proteomics Services Market Size Value by Research Areas (2021-2026) & (USD Million)
Table 37. World Blood Proteomics Services Market Size by Research Areas (2027-2032) & (USD Million)
Table 38. World Blood Proteomics Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Blood Proteomics Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Blood Proteomics Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Olink (Thermo Fisher Scientific) Basic Information, Manufacturing Base and Competitors
Table 42. Olink (Thermo Fisher Scientific) Major Business
Table 43. Olink (Thermo Fisher Scientific) Blood Proteomics Services Product and Services
Table 44. Olink (Thermo Fisher Scientific) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Olink (Thermo Fisher Scientific) Recent Developments/Updates
Table 46. Olink (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 47. SomaLogic (Illumina) Basic Information, Manufacturing Base and Competitors
Table 48. SomaLogic (Illumina) Major Business
Table 49. SomaLogic (Illumina) Blood Proteomics Services Product and Services
Table 50. SomaLogic (Illumina) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. SomaLogic (Illumina) Recent Developments/Updates
Table 52. SomaLogic (Illumina) Competitive Strengths & Weaknesses
Table 53. Labcorp Basic Information, Manufacturing Base and Competitors
Table 54. Labcorp Major Business
Table 55. Labcorp Blood Proteomics Services Product and Services
Table 56. Labcorp Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Labcorp Recent Developments/Updates
Table 58. Labcorp Competitive Strengths & Weaknesses
Table 59. BostonGene Basic Information, Manufacturing Base and Competitors
Table 60. BostonGene Major Business
Table 61. BostonGene Blood Proteomics Services Product and Services
Table 62. BostonGene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. BostonGene Recent Developments/Updates
Table 64. BostonGene Competitive Strengths & Weaknesses
Table 65. CellCarta Basic Information, Manufacturing Base and Competitors
Table 66. CellCarta Major Business
Table 67. CellCarta Blood Proteomics Services Product and Services
Table 68. CellCarta Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CellCarta Recent Developments/Updates
Table 70. CellCarta Competitive Strengths & Weaknesses
Table 71. GENEWIZ (Azenta Life Sciences) Basic Information, Manufacturing Base and Competitors
Table 72. GENEWIZ (Azenta Life Sciences) Major Business
Table 73. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product and Services
Table 74. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GENEWIZ (Azenta Life Sciences) Recent Developments/Updates
Table 76. GENEWIZ (Azenta Life Sciences) Competitive Strengths & Weaknesses
Table 77. CDI Labs Basic Information, Manufacturing Base and Competitors
Table 78. CDI Labs Major Business
Table 79. CDI Labs Blood Proteomics Services Product and Services
Table 80. CDI Labs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CDI Labs Recent Developments/Updates
Table 82. CDI Labs Competitive Strengths & Weaknesses
Table 83. Biognosys Basic Information, Manufacturing Base and Competitors
Table 84. Biognosys Major Business
Table 85. Biognosys Blood Proteomics Services Product and Services
Table 86. Biognosys Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Biognosys Recent Developments/Updates
Table 88. Biognosys Competitive Strengths & Weaknesses
Table 89. Discovery Life Sciences Basic Information, Manufacturing Base and Competitors
Table 90. Discovery Life Sciences Major Business
Table 91. Discovery Life Sciences Blood Proteomics Services Product and Services
Table 92. Discovery Life Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Discovery Life Sciences Recent Developments/Updates
Table 94. Discovery Life Sciences Competitive Strengths & Weaknesses
Table 95. Firalis Molecular Precision Basic Information, Manufacturing Base and Competitors
Table 96. Firalis Molecular Precision Major Business
Table 97. Firalis Molecular Precision Blood Proteomics Services Product and Services
Table 98. Firalis Molecular Precision Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Firalis Molecular Precision Recent Developments/Updates
Table 100. Firalis Molecular Precision Competitive Strengths & Weaknesses
Table 101. Cell Signaling Technology (CST) Basic Information, Manufacturing Base and Competitors
Table 102. Cell Signaling Technology (CST) Major Business
Table 103. Cell Signaling Technology (CST) Blood Proteomics Services Product and Services
Table 104. Cell Signaling Technology (CST) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cell Signaling Technology (CST) Recent Developments/Updates
Table 106. Cell Signaling Technology (CST) Competitive Strengths & Weaknesses
Table 107. Sampled (Infinity Biologix) Basic Information, Manufacturing Base and Competitors
Table 108. Sampled (Infinity Biologix) Major Business
Table 109. Sampled (Infinity Biologix) Blood Proteomics Services Product and Services
Table 110. Sampled (Infinity Biologix) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Sampled (Infinity Biologix) Recent Developments/Updates
Table 112. Sampled (Infinity Biologix) Competitive Strengths & Weaknesses
Table 113. APTBIO Basic Information, Manufacturing Base and Competitors
Table 114. APTBIO Major Business
Table 115. APTBIO Blood Proteomics Services Product and Services
Table 116. APTBIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. APTBIO Recent Developments/Updates
Table 118. APTBIO Competitive Strengths & Weaknesses
Table 119. Sinotech Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Sinotech Genomics Major Business
Table 121. Sinotech Genomics Blood Proteomics Services Product and Services
Table 122. Sinotech Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sinotech Genomics Recent Developments/Updates
Table 124. Sinotech Genomics Competitive Strengths & Weaknesses
Table 125. Biodesix Basic Information, Manufacturing Base and Competitors
Table 126. Biodesix Major Business
Table 127. Biodesix Blood Proteomics Services Product and Services
Table 128. Biodesix Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Biodesix Recent Developments/Updates
Table 130. Biodesix Competitive Strengths & Weaknesses
Table 131. Panome Bio Basic Information, Manufacturing Base and Competitors
Table 132. Panome Bio Major Business
Table 133. Panome Bio Blood Proteomics Services Product and Services
Table 134. Panome Bio Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Panome Bio Recent Developments/Updates
Table 136. Panome Bio Competitive Strengths & Weaknesses
Table 137. Novogene Basic Information, Manufacturing Base and Competitors
Table 138. Novogene Major Business
Table 139. Novogene Blood Proteomics Services Product and Services
Table 140. Novogene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Novogene Recent Developments/Updates
Table 142. Novogene Competitive Strengths & Weaknesses
Table 143. PTM BIO Basic Information, Manufacturing Base and Competitors
Table 144. PTM BIO Major Business
Table 145. PTM BIO Blood Proteomics Services Product and Services
Table 146. PTM BIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. PTM BIO Recent Developments/Updates
Table 148. PTM BIO Competitive Strengths & Weaknesses
Table 149. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 150. BGI Genomics Major Business
Table 151. BGI Genomics Blood Proteomics Services Product and Services
Table 152. BGI Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. BGI Genomics Recent Developments/Updates
Table 154. BGI Genomics Competitive Strengths & Weaknesses
Table 155. Evotec Basic Information, Manufacturing Base and Competitors
Table 156. Evotec Major Business
Table 157. Evotec Blood Proteomics Services Product and Services
Table 158. Evotec Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Evotec Recent Developments/Updates
Table 160. Evotec Competitive Strengths & Weaknesses
Table 161. Metware Biotechnology Basic Information, Manufacturing Base and Competitors
Table 162. Metware Biotechnology Major Business
Table 163. Metware Biotechnology Blood Proteomics Services Product and Services
Table 164. Metware Biotechnology Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Metware Biotechnology Recent Developments/Updates
Table 166. Metware Biotechnology Competitive Strengths & Weaknesses
Table 167. MRM Proteomics Basic Information, Manufacturing Base and Competitors
Table 168. MRM Proteomics Major Business
Table 169. MRM Proteomics Blood Proteomics Services Product and Services
Table 170. MRM Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. MRM Proteomics Recent Developments/Updates
Table 172. MRM Proteomics Competitive Strengths & Weaknesses
Table 173. Lc-Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 174. Lc-Bio Technologies Major Business
Table 175. Lc-Bio Technologies Blood Proteomics Services Product and Services
Table 176. Lc-Bio Technologies Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Lc-Bio Technologies Recent Developments/Updates
Table 178. Lc-Bio Technologies Competitive Strengths & Weaknesses
Table 179. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 180. Eurofins Scientific Major Business
Table 181. Eurofins Scientific Blood Proteomics Services Product and Services
Table 182. Eurofins Scientific Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Eurofins Scientific Recent Developments/Updates
Table 184. Eurofins Scientific Competitive Strengths & Weaknesses
Table 185. MtoZ-Biolabs Basic Information, Manufacturing Base and Competitors
Table 186. MtoZ-Biolabs Major Business
Table 187. MtoZ-Biolabs Blood Proteomics Services Product and Services
Table 188. MtoZ-Biolabs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. MtoZ-Biolabs Recent Developments/Updates
Table 190. MtoZ-Biolabs Competitive Strengths & Weaknesses
Table 191. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 192. Creative Proteomics Major Business
Table 193. Creative Proteomics Blood Proteomics Services Product and Services
Table 194. Creative Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Creative Proteomics Recent Developments/Updates
Table 196. Creative Proteomics Competitive Strengths & Weaknesses
Table 197. Macrogen Basic Information, Manufacturing Base and Competitors
Table 198. Macrogen Major Business
Table 199. Macrogen Blood Proteomics Services Product and Services
Table 200. Macrogen Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Macrogen Recent Developments/Updates
Table 202. Macrogen Competitive Strengths & Weaknesses
Table 203. TATAA Biocenter Basic Information, Manufacturing Base and Competitors
Table 204. TATAA Biocenter Major Business
Table 205. TATAA Biocenter Blood Proteomics Services Product and Services
Table 206. TATAA Biocenter Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. TATAA Biocenter Recent Developments/Updates
Table 208. TATAA Biocenter Competitive Strengths & Weaknesses
Table 209. OmicScouts (Momentum Biotechnologies) Basic Information, Manufacturing Base and Competitors
Table 210. OmicScouts (Momentum Biotechnologies) Major Business
Table 211. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product and Services
Table 212. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. OmicScouts (Momentum Biotechnologies) Recent Developments/Updates
Table 214. OmicScouts (Momentum Biotechnologies) Competitive Strengths & Weaknesses
Table 215. Precision Biomarker Laboratories (PBL) Basic Information, Manufacturing Base and Competitors
Table 216. Precision Biomarker Laboratories (PBL) Major Business
Table 217. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product and Services
Table 218. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Precision Biomarker Laboratories (PBL) Recent Developments/Updates
Table 220. Precision Biomarker Laboratories (PBL) Competitive Strengths & Weaknesses
Table 221. Shanghai OE Biotech Basic Information, Manufacturing Base and Competitors
Table 222. Shanghai OE Biotech Major Business
Table 223. Shanghai OE Biotech Blood Proteomics Services Product and Services
Table 224. Shanghai OE Biotech Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Shanghai OE Biotech Recent Developments/Updates
Table 226. Shanghai OE Biotech Competitive Strengths & Weaknesses
Table 227. RxCelerate Basic Information, Manufacturing Base and Competitors
Table 228. RxCelerate Major Business
Table 229. RxCelerate Blood Proteomics Services Product and Services
Table 230. RxCelerate Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. RxCelerate Recent Developments/Updates
Table 232. RxCelerate Competitive Strengths & Weaknesses
Table 233. Proteomics International Basic Information, Manufacturing Base and Competitors
Table 234. Proteomics International Major Business
Table 235. Proteomics International Blood Proteomics Services Product and Services
Table 236. Proteomics International Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Proteomics International Recent Developments/Updates
Table 238. Proteomics International Competitive Strengths & Weaknesses
Table 239. Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table 240. Proteome Sciences Major Business
Table 241. Proteome Sciences Blood Proteomics Services Product and Services
Table 242. Proteome Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. Proteome Sciences Recent Developments/Updates
Table 244. Proteome Sciences Competitive Strengths & Weaknesses
Table 245. Westlake Omics Basic Information, Manufacturing Base and Competitors
Table 246. Westlake Omics Major Business
Table 247. Westlake Omics Blood Proteomics Services Product and Services
Table 248. Westlake Omics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. Westlake Omics Recent Developments/Updates
Table 250. Westlake Omics Competitive Strengths & Weaknesses
Table 251. Crown Bioscience Basic Information, Manufacturing Base and Competitors
Table 252. Crown Bioscience Major Business
Table 253. Crown Bioscience Blood Proteomics Services Product and Services
Table 254. Crown Bioscience Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. Crown Bioscience Recent Developments/Updates
Table 256. Crown Bioscience Competitive Strengths & Weaknesses
Table 257. VProteomics Basic Information, Manufacturing Base and Competitors
Table 258. VProteomics Major Business
Table 259. VProteomics Blood Proteomics Services Product and Services
Table 260. VProteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. VProteomics Recent Developments/Updates
Table 262. VProteomics Competitive Strengths & Weaknesses
Table 263. Shanghai Majorbio Bio-Pharm Basic Information, Manufacturing Base and Competitors
Table 264. Shanghai Majorbio Bio-Pharm Major Business
Table 265. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product and Services
Table 266. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Shanghai Majorbio Bio-Pharm Recent Developments/Updates
Table 268. Shanghai Majorbio Bio-Pharm Competitive Strengths & Weaknesses
Table 269. Applied Biomics Basic Information, Manufacturing Base and Competitors
Table 270. Applied Biomics Major Business
Table 271. Applied Biomics Blood Proteomics Services Product and Services
Table 272. Applied Biomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Applied Biomics Recent Developments/Updates
Table 274. Applied Biomics Competitive Strengths & Weaknesses
Table 275. Sapient Bioanalytics Basic Information, Manufacturing Base and Competitors
Table 276. Sapient Bioanalytics Major Business
Table 277. Sapient Bioanalytics Blood Proteomics Services Product and Services
Table 278. Sapient Bioanalytics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 279. Sapient Bioanalytics Recent Developments/Updates
Table 280. Sapient Bioanalytics Competitive Strengths & Weaknesses
Table 281. Global Key Players of Blood Proteomics Services Upstream (Raw Materials)
Table 282. Global Blood Proteomics Services Typical Customers
Table 1. World Blood Proteomics Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Blood Proteomics Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Blood Proteomics Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Blood Proteomics Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Blood Proteomics Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Blood Proteomics Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Blood Proteomics Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Blood Proteomics Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Blood Proteomics Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Blood Proteomics Services Players in 2025
Table 12. World Blood Proteomics Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Blood Proteomics Services Company Evaluation Quadrant
Table 14. Head Office of Key Blood Proteomics Services Players
Table 15. Blood Proteomics Services Market: Company Product Type Footprint
Table 16. Blood Proteomics Services Market: Company Product Application Footprint
Table 17. Blood Proteomics Services Mergers & Acquisitions Activity
Table 18. United States VS China Blood Proteomics Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Blood Proteomics Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Blood Proteomics Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Blood Proteomics Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Blood Proteomics Services Revenue Market Share (2021-2026)
Table 23. China Based Blood Proteomics Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Blood Proteomics Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Blood Proteomics Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Blood Proteomics Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Blood Proteomics Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Blood Proteomics Services Revenue Market Share (2021-2026)
Table 29. World Blood Proteomics Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Blood Proteomics Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Blood Proteomics Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Blood Proteomics Services Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 33. World Blood Proteomics Services Market Size Value by End User (2021-2026) & (USD Million)
Table 34. World Blood Proteomics Services Market Size by End User (2027-2032) & (USD Million)
Table 35. World Blood Proteomics Services Market Size by Research Areas, (USD Million), 2021 & 2025 & 2032
Table 36. World Blood Proteomics Services Market Size Value by Research Areas (2021-2026) & (USD Million)
Table 37. World Blood Proteomics Services Market Size by Research Areas (2027-2032) & (USD Million)
Table 38. World Blood Proteomics Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Blood Proteomics Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Blood Proteomics Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Olink (Thermo Fisher Scientific) Basic Information, Manufacturing Base and Competitors
Table 42. Olink (Thermo Fisher Scientific) Major Business
Table 43. Olink (Thermo Fisher Scientific) Blood Proteomics Services Product and Services
Table 44. Olink (Thermo Fisher Scientific) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Olink (Thermo Fisher Scientific) Recent Developments/Updates
Table 46. Olink (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 47. SomaLogic (Illumina) Basic Information, Manufacturing Base and Competitors
Table 48. SomaLogic (Illumina) Major Business
Table 49. SomaLogic (Illumina) Blood Proteomics Services Product and Services
Table 50. SomaLogic (Illumina) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. SomaLogic (Illumina) Recent Developments/Updates
Table 52. SomaLogic (Illumina) Competitive Strengths & Weaknesses
Table 53. Labcorp Basic Information, Manufacturing Base and Competitors
Table 54. Labcorp Major Business
Table 55. Labcorp Blood Proteomics Services Product and Services
Table 56. Labcorp Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Labcorp Recent Developments/Updates
Table 58. Labcorp Competitive Strengths & Weaknesses
Table 59. BostonGene Basic Information, Manufacturing Base and Competitors
Table 60. BostonGene Major Business
Table 61. BostonGene Blood Proteomics Services Product and Services
Table 62. BostonGene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. BostonGene Recent Developments/Updates
Table 64. BostonGene Competitive Strengths & Weaknesses
Table 65. CellCarta Basic Information, Manufacturing Base and Competitors
Table 66. CellCarta Major Business
Table 67. CellCarta Blood Proteomics Services Product and Services
Table 68. CellCarta Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CellCarta Recent Developments/Updates
Table 70. CellCarta Competitive Strengths & Weaknesses
Table 71. GENEWIZ (Azenta Life Sciences) Basic Information, Manufacturing Base and Competitors
Table 72. GENEWIZ (Azenta Life Sciences) Major Business
Table 73. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product and Services
Table 74. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GENEWIZ (Azenta Life Sciences) Recent Developments/Updates
Table 76. GENEWIZ (Azenta Life Sciences) Competitive Strengths & Weaknesses
Table 77. CDI Labs Basic Information, Manufacturing Base and Competitors
Table 78. CDI Labs Major Business
Table 79. CDI Labs Blood Proteomics Services Product and Services
Table 80. CDI Labs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CDI Labs Recent Developments/Updates
Table 82. CDI Labs Competitive Strengths & Weaknesses
Table 83. Biognosys Basic Information, Manufacturing Base and Competitors
Table 84. Biognosys Major Business
Table 85. Biognosys Blood Proteomics Services Product and Services
Table 86. Biognosys Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Biognosys Recent Developments/Updates
Table 88. Biognosys Competitive Strengths & Weaknesses
Table 89. Discovery Life Sciences Basic Information, Manufacturing Base and Competitors
Table 90. Discovery Life Sciences Major Business
Table 91. Discovery Life Sciences Blood Proteomics Services Product and Services
Table 92. Discovery Life Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Discovery Life Sciences Recent Developments/Updates
Table 94. Discovery Life Sciences Competitive Strengths & Weaknesses
Table 95. Firalis Molecular Precision Basic Information, Manufacturing Base and Competitors
Table 96. Firalis Molecular Precision Major Business
Table 97. Firalis Molecular Precision Blood Proteomics Services Product and Services
Table 98. Firalis Molecular Precision Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Firalis Molecular Precision Recent Developments/Updates
Table 100. Firalis Molecular Precision Competitive Strengths & Weaknesses
Table 101. Cell Signaling Technology (CST) Basic Information, Manufacturing Base and Competitors
Table 102. Cell Signaling Technology (CST) Major Business
Table 103. Cell Signaling Technology (CST) Blood Proteomics Services Product and Services
Table 104. Cell Signaling Technology (CST) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cell Signaling Technology (CST) Recent Developments/Updates
Table 106. Cell Signaling Technology (CST) Competitive Strengths & Weaknesses
Table 107. Sampled (Infinity Biologix) Basic Information, Manufacturing Base and Competitors
Table 108. Sampled (Infinity Biologix) Major Business
Table 109. Sampled (Infinity Biologix) Blood Proteomics Services Product and Services
Table 110. Sampled (Infinity Biologix) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Sampled (Infinity Biologix) Recent Developments/Updates
Table 112. Sampled (Infinity Biologix) Competitive Strengths & Weaknesses
Table 113. APTBIO Basic Information, Manufacturing Base and Competitors
Table 114. APTBIO Major Business
Table 115. APTBIO Blood Proteomics Services Product and Services
Table 116. APTBIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. APTBIO Recent Developments/Updates
Table 118. APTBIO Competitive Strengths & Weaknesses
Table 119. Sinotech Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Sinotech Genomics Major Business
Table 121. Sinotech Genomics Blood Proteomics Services Product and Services
Table 122. Sinotech Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sinotech Genomics Recent Developments/Updates
Table 124. Sinotech Genomics Competitive Strengths & Weaknesses
Table 125. Biodesix Basic Information, Manufacturing Base and Competitors
Table 126. Biodesix Major Business
Table 127. Biodesix Blood Proteomics Services Product and Services
Table 128. Biodesix Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Biodesix Recent Developments/Updates
Table 130. Biodesix Competitive Strengths & Weaknesses
Table 131. Panome Bio Basic Information, Manufacturing Base and Competitors
Table 132. Panome Bio Major Business
Table 133. Panome Bio Blood Proteomics Services Product and Services
Table 134. Panome Bio Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Panome Bio Recent Developments/Updates
Table 136. Panome Bio Competitive Strengths & Weaknesses
Table 137. Novogene Basic Information, Manufacturing Base and Competitors
Table 138. Novogene Major Business
Table 139. Novogene Blood Proteomics Services Product and Services
Table 140. Novogene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Novogene Recent Developments/Updates
Table 142. Novogene Competitive Strengths & Weaknesses
Table 143. PTM BIO Basic Information, Manufacturing Base and Competitors
Table 144. PTM BIO Major Business
Table 145. PTM BIO Blood Proteomics Services Product and Services
Table 146. PTM BIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. PTM BIO Recent Developments/Updates
Table 148. PTM BIO Competitive Strengths & Weaknesses
Table 149. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 150. BGI Genomics Major Business
Table 151. BGI Genomics Blood Proteomics Services Product and Services
Table 152. BGI Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. BGI Genomics Recent Developments/Updates
Table 154. BGI Genomics Competitive Strengths & Weaknesses
Table 155. Evotec Basic Information, Manufacturing Base and Competitors
Table 156. Evotec Major Business
Table 157. Evotec Blood Proteomics Services Product and Services
Table 158. Evotec Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Evotec Recent Developments/Updates
Table 160. Evotec Competitive Strengths & Weaknesses
Table 161. Metware Biotechnology Basic Information, Manufacturing Base and Competitors
Table 162. Metware Biotechnology Major Business
Table 163. Metware Biotechnology Blood Proteomics Services Product and Services
Table 164. Metware Biotechnology Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Metware Biotechnology Recent Developments/Updates
Table 166. Metware Biotechnology Competitive Strengths & Weaknesses
Table 167. MRM Proteomics Basic Information, Manufacturing Base and Competitors
Table 168. MRM Proteomics Major Business
Table 169. MRM Proteomics Blood Proteomics Services Product and Services
Table 170. MRM Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. MRM Proteomics Recent Developments/Updates
Table 172. MRM Proteomics Competitive Strengths & Weaknesses
Table 173. Lc-Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 174. Lc-Bio Technologies Major Business
Table 175. Lc-Bio Technologies Blood Proteomics Services Product and Services
Table 176. Lc-Bio Technologies Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Lc-Bio Technologies Recent Developments/Updates
Table 178. Lc-Bio Technologies Competitive Strengths & Weaknesses
Table 179. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 180. Eurofins Scientific Major Business
Table 181. Eurofins Scientific Blood Proteomics Services Product and Services
Table 182. Eurofins Scientific Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Eurofins Scientific Recent Developments/Updates
Table 184. Eurofins Scientific Competitive Strengths & Weaknesses
Table 185. MtoZ-Biolabs Basic Information, Manufacturing Base and Competitors
Table 186. MtoZ-Biolabs Major Business
Table 187. MtoZ-Biolabs Blood Proteomics Services Product and Services
Table 188. MtoZ-Biolabs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. MtoZ-Biolabs Recent Developments/Updates
Table 190. MtoZ-Biolabs Competitive Strengths & Weaknesses
Table 191. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 192. Creative Proteomics Major Business
Table 193. Creative Proteomics Blood Proteomics Services Product and Services
Table 194. Creative Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Creative Proteomics Recent Developments/Updates
Table 196. Creative Proteomics Competitive Strengths & Weaknesses
Table 197. Macrogen Basic Information, Manufacturing Base and Competitors
Table 198. Macrogen Major Business
Table 199. Macrogen Blood Proteomics Services Product and Services
Table 200. Macrogen Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Macrogen Recent Developments/Updates
Table 202. Macrogen Competitive Strengths & Weaknesses
Table 203. TATAA Biocenter Basic Information, Manufacturing Base and Competitors
Table 204. TATAA Biocenter Major Business
Table 205. TATAA Biocenter Blood Proteomics Services Product and Services
Table 206. TATAA Biocenter Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. TATAA Biocenter Recent Developments/Updates
Table 208. TATAA Biocenter Competitive Strengths & Weaknesses
Table 209. OmicScouts (Momentum Biotechnologies) Basic Information, Manufacturing Base and Competitors
Table 210. OmicScouts (Momentum Biotechnologies) Major Business
Table 211. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product and Services
Table 212. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. OmicScouts (Momentum Biotechnologies) Recent Developments/Updates
Table 214. OmicScouts (Momentum Biotechnologies) Competitive Strengths & Weaknesses
Table 215. Precision Biomarker Laboratories (PBL) Basic Information, Manufacturing Base and Competitors
Table 216. Precision Biomarker Laboratories (PBL) Major Business
Table 217. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product and Services
Table 218. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Precision Biomarker Laboratories (PBL) Recent Developments/Updates
Table 220. Precision Biomarker Laboratories (PBL) Competitive Strengths & Weaknesses
Table 221. Shanghai OE Biotech Basic Information, Manufacturing Base and Competitors
Table 222. Shanghai OE Biotech Major Business
Table 223. Shanghai OE Biotech Blood Proteomics Services Product and Services
Table 224. Shanghai OE Biotech Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Shanghai OE Biotech Recent Developments/Updates
Table 226. Shanghai OE Biotech Competitive Strengths & Weaknesses
Table 227. RxCelerate Basic Information, Manufacturing Base and Competitors
Table 228. RxCelerate Major Business
Table 229. RxCelerate Blood Proteomics Services Product and Services
Table 230. RxCelerate Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. RxCelerate Recent Developments/Updates
Table 232. RxCelerate Competitive Strengths & Weaknesses
Table 233. Proteomics International Basic Information, Manufacturing Base and Competitors
Table 234. Proteomics International Major Business
Table 235. Proteomics International Blood Proteomics Services Product and Services
Table 236. Proteomics International Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Proteomics International Recent Developments/Updates
Table 238. Proteomics International Competitive Strengths & Weaknesses
Table 239. Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table 240. Proteome Sciences Major Business
Table 241. Proteome Sciences Blood Proteomics Services Product and Services
Table 242. Proteome Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. Proteome Sciences Recent Developments/Updates
Table 244. Proteome Sciences Competitive Strengths & Weaknesses
Table 245. Westlake Omics Basic Information, Manufacturing Base and Competitors
Table 246. Westlake Omics Major Business
Table 247. Westlake Omics Blood Proteomics Services Product and Services
Table 248. Westlake Omics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. Westlake Omics Recent Developments/Updates
Table 250. Westlake Omics Competitive Strengths & Weaknesses
Table 251. Crown Bioscience Basic Information, Manufacturing Base and Competitors
Table 252. Crown Bioscience Major Business
Table 253. Crown Bioscience Blood Proteomics Services Product and Services
Table 254. Crown Bioscience Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. Crown Bioscience Recent Developments/Updates
Table 256. Crown Bioscience Competitive Strengths & Weaknesses
Table 257. VProteomics Basic Information, Manufacturing Base and Competitors
Table 258. VProteomics Major Business
Table 259. VProteomics Blood Proteomics Services Product and Services
Table 260. VProteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. VProteomics Recent Developments/Updates
Table 262. VProteomics Competitive Strengths & Weaknesses
Table 263. Shanghai Majorbio Bio-Pharm Basic Information, Manufacturing Base and Competitors
Table 264. Shanghai Majorbio Bio-Pharm Major Business
Table 265. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product and Services
Table 266. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Shanghai Majorbio Bio-Pharm Recent Developments/Updates
Table 268. Shanghai Majorbio Bio-Pharm Competitive Strengths & Weaknesses
Table 269. Applied Biomics Basic Information, Manufacturing Base and Competitors
Table 270. Applied Biomics Major Business
Table 271. Applied Biomics Blood Proteomics Services Product and Services
Table 272. Applied Biomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Applied Biomics Recent Developments/Updates
Table 274. Applied Biomics Competitive Strengths & Weaknesses
Table 275. Sapient Bioanalytics Basic Information, Manufacturing Base and Competitors
Table 276. Sapient Bioanalytics Major Business
Table 277. Sapient Bioanalytics Blood Proteomics Services Product and Services
Table 278. Sapient Bioanalytics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 279. Sapient Bioanalytics Recent Developments/Updates
Table 280. Sapient Bioanalytics Competitive Strengths & Weaknesses
Table 281. Global Key Players of Blood Proteomics Services Upstream (Raw Materials)
Table 282. Global Blood Proteomics Services Typical Customers
LIST OF FIGURES
Figure 1. Blood Proteomics Services Picture
Figure 2. World Blood Proteomics Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Blood Proteomics Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Blood Proteomics Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Blood Proteomics Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 13. Blood Proteomics Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Blood Proteomics Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Blood Proteomics Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Blood Proteomics Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Blood Proteomics Services Markets in 2025
Figure 27. United States VS China: Blood Proteomics Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Blood Proteomics Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Blood Proteomics Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Blood Proteomics Services Market Size Market Share by Type in 2025
Figure 31. Blood Proteomics
Figure 32. Blood Modification Proteomics
Figure 33. Olink (Targeted) Proteomics
Figure 34. World Blood Proteomics Services Market Size Market Share by Type (2021-2032)
Figure 35. World Blood Proteomics Services Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 36. World Blood Proteomics Services Market Size Market Share by End User in 2025
Figure 37. Universities and Research Institutes
Figure 38. Hospitals
Figure 39. Pharmaceutical Companies
Figure 40. Others
Figure 41. World Blood Proteomics Services Market Size Market Share by End User (2021-2032)
Figure 42. World Blood Proteomics Services Market Size by Research Areas, (USD Million), 2021 & 2025 & 2032
Figure 43. World Blood Proteomics Services Market Size Market Share by Research Areas in 2025
Figure 44. Oncology
Figure 45. Cardiovascular
Figure 46. Agriculture
Figure 47. Neuroscience
Figure 48. Other
Figure 49. World Blood Proteomics Services Market Size Market Share by Research Areas (2021-2032)
Figure 50. World Blood Proteomics Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Blood Proteomics Services Market Size Market Share by Application in 2025
Figure 52. Disease Biomarker Research
Figure 53. Drug Development
Figure 54. Clinical Research
Figure 55. Others
Figure 56. World Blood Proteomics Services Market Size Market Share by Application (2021-2032)
Figure 57. Blood Proteomics Services Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. Blood Proteomics Services Picture
Figure 2. World Blood Proteomics Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Blood Proteomics Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Blood Proteomics Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Blood Proteomics Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Blood Proteomics Services Revenue (2021-2032) & (USD Million)
Figure 13. Blood Proteomics Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Blood Proteomics Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Blood Proteomics Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Blood Proteomics Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Blood Proteomics Services Markets in 2025
Figure 27. United States VS China: Blood Proteomics Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Blood Proteomics Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Blood Proteomics Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Blood Proteomics Services Market Size Market Share by Type in 2025
Figure 31. Blood Proteomics
Figure 32. Blood Modification Proteomics
Figure 33. Olink (Targeted) Proteomics
Figure 34. World Blood Proteomics Services Market Size Market Share by Type (2021-2032)
Figure 35. World Blood Proteomics Services Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 36. World Blood Proteomics Services Market Size Market Share by End User in 2025
Figure 37. Universities and Research Institutes
Figure 38. Hospitals
Figure 39. Pharmaceutical Companies
Figure 40. Others
Figure 41. World Blood Proteomics Services Market Size Market Share by End User (2021-2032)
Figure 42. World Blood Proteomics Services Market Size by Research Areas, (USD Million), 2021 & 2025 & 2032
Figure 43. World Blood Proteomics Services Market Size Market Share by Research Areas in 2025
Figure 44. Oncology
Figure 45. Cardiovascular
Figure 46. Agriculture
Figure 47. Neuroscience
Figure 48. Other
Figure 49. World Blood Proteomics Services Market Size Market Share by Research Areas (2021-2032)
Figure 50. World Blood Proteomics Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Blood Proteomics Services Market Size Market Share by Application in 2025
Figure 52. Disease Biomarker Research
Figure 53. Drug Development
Figure 54. Clinical Research
Figure 55. Others
Figure 56. World Blood Proteomics Services Market Size Market Share by Application (2021-2032)
Figure 57. Blood Proteomics Services Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
